- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04560803
Epidermal Skin Grafts to Improve Healing In Radiation Wounds
Using Autologous Epidermal Skin Micrografts to Improve Healing In Radiation Wounds: A Pilot Study
Patients undergoing radiation for the treatment of malignancies may suffer from side effects to the skin in the form of radiation dermatitis. This can lead to local wound formation with poor healing. Treatment options for the resulting wound can range from watchful waiting to more aggressive debridement and secondary grafting.
Epidermal grafting is a technique in which autologous epidermis is used to cover wounds that are larger than the donor site. Previous studies have demonstrated that this is an effective treatment for different wounds and ulcers but its utility has not yet been evaluated for the treatment of radiation induced injuries.
The CelluTome Epidermal Grafting System is a semi automated device that allows easy formation of epidermal Blister.
Our study will evaluate the efficacy of epidermal grafts collected using the CelluTome device in the treatment of radiation dermatitis.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients participating in this study will undergo the epidermal grafting procedure to a part of their radiation-induced wound. The remaining untreated area will serve as an irradiated control.
The donor tissue will be collected from normal skin in the upper thigh area. In addition to their primary screening visit, patients will be followed up closely in a series of 9 study visits. During these sessions, photographs will be taken and patients will be asked to fill out questionnaires.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Katie Vogel
- Phone Number: 6177242168
- Email: kevogel@mgh.harvard.edu
Study Contact Backup
- Name: Elizabeth Morehouse
- Phone Number: 6177242168
- Email: emorehouse@partners.org
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Recruiting
- Massachusetts General Hospital, Wellman Center for Photomedicine
-
Contact:
- Elizabeth Morehouse
- Phone Number: 6177242168
- Email: emorehouse@partners.org
-
Contact:
- Katie Vogel
- Phone Number: 617-724-2168
- Email: kevogel@mgh.harvard.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Status post radiation treatment, with radiation-induced wound. This includes patient with moist desquamation as well as full epidermal necrosis and superficial dermal ulcerations, this wound would otherwise be allowed to heal by secondary intention;
- Having suitable areas of treatment: All wounds in the area of interest must be at least 20 cm2 (~10 cm2 per treatment/control area);
- The radiation injury must have a suitable adjacent irradiated control site before initiation of treatment. This will be determined by objective measurements of % wound epithelization, wound erythema, pliability, induration and thickness at enrollment;
- Able and willing to comply with all visit, treatment and evaluation schedules and requirements;
- Wound considered appropriate by physician to receive epidermal grafting;
- Able to understand and provide written informed consent;
Exclusion Criteria:
- Active tanning, including the use of tanning booths, during the course of the study;
- Study wound exhibits clinical signs and symptoms of infection at the screening/enrollment visit;
- Patient unable to provide donor site for epidermal harvesting;
- Wound sites located on the face, hands or feet
- Adverse reactions to compounds of any external agent (e.g., gels, lotions or anesthetic creams) required for use in the study, if no alternative to the said agent exists;
- History of collagen vascular disease;
- Active Herpes Simplex or Zoster at the time of treatment or having experienced more than three episodes of Herpes Simplex / Zoster eruption within a year of study enrollment;
- History of immunosuppression/immune deficiency disorders (including human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) or use of immunosuppressive medications;
- Significant concurrent illness, such as uncontrolled diabetes (with a hemoglobin A1C of more than 8) (i.e., any disease state that in the opinion of the Investigator would interfere with the anesthesia, treatment, or healing process);
- Mentally incompetent, prisoner or evidence of active substance or alcohol abuse;
- Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or study personnel) to treat the subject as part of this research study;
- Participation in another interventional study with potential exposure to an investigational drug within past 30 days;
- Pregnant females, due to possible discomfort with the procedure even though the procedure is localized and there is no new drug.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Epidermal Grafting
This irradiated area of the skin will be treated with autologous epidermal grafts
|
Autologous epidermal grafts that will be placed at the treatment site
|
No Intervention: No treatment
This irradiated area will not receive any treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the CTCAE (National Cancer Institute Common Terminology Criteria for Adverse Events v5) grading
Time Frame: 12 months
|
Patients will receive a grading for their treated radiation wound based on the CTCAE.
Changes in the grading over time will be used to assess improvement of the wound
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Yen-Lin E Chen, MD, Massachusetts General Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019P001728
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiation Dermatitis
-
Chang Gung Memorial HospitalNot yet recruiting
-
German University in CairoAin Shams UniversityCompleted
-
China Medical University HospitalCompletedRadiation DermatitisTaiwan
-
Sheba Medical CenterFerring PharmaceuticalsCompleted
-
Apeiron BiologicsCompleted
-
Lutris Pharma Ltd.CompletedRadiation DermatitisUnited States
-
University of RochesterNational Cancer Institute (NCI)CompletedRadiation-induced Dermatitis
-
University of the PhilippinesRecruitingAcute Radiation DermatitisPhilippines
-
China Medical University HospitalNot yet recruitingBreast Cancer | Radiation Dermatitis
-
Pharm Olam Pharmaceuticals Ltd.UnknownPrevention of Radiation Induced Dermatitis.
Clinical Trials on CelluTomeTM Epidermal Harvesting System
-
Masonic Cancer Center, University of MinnesotaCompletedEpidermolysis BullosaUnited States
-
Momelan TechnologiesUnknownNeoplasm of SkinUnited States
-
Momelan TechnologiesUnknownSurgical Wound | Hypo-pigmented SkinUnited States
-
LifeBridge HealthKinetic Concepts, Inc.WithdrawnWounds and InjuriesUnited States
-
Massachusetts General HospitalTerminatedActinic Keratosis | Extensive Photodamage | History of Numerous Skin CancersUnited States
-
Assistance Publique - Hôpitaux de ParisTerminated
-
Avita MedicalBiomedical Advanced Research and Development AuthorityTerminatedSkin; DeformityUnited States
-
Avita MedicalBiomedical Advanced Research and Development AuthorityTerminated
-
Unity Health TorontoUnknownNonunion of Bone Graft | Fractures Non UnionCanada